Historique de carrière de Kristin Gustafson
Anciens postes connus de Kristin Gustafson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MIRATI THERAPEUTICS | Responsable des Ressources Humaines | 01/01/2020 | 23/01/2024 |
| Chemo101, Inc. | Fondateur | - | - |
| INTERCEPT PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | - | - |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
| TURNSTONE BIOLOGICS CORP. | Responsable des Ressources Humaines | - | - |
Formation de Kristin Gustafson
| University of Wisconsin | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Human Resources Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
| Chemo101, Inc. |
- Bourse
- Insiders
- Kristin Gustafson
- Expérience